Guanidine derivative compounds
US-9775355-B2 · Oct 3, 2017 · US
US9975847B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9975847-B2 |
| Application number | US-201514938334-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 11, 2015 |
| Priority date | Nov 11, 2014 |
| Publication date | May 22, 2018 |
| Grant date | May 22, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are compounds described by the Formula I: wherein: R 1 is a linear or branched, saturated or unsaturated aliphatic group having from 5 to 22 carbon atoms; R 2 is selected from the group consisting of the functional groups: and salts thereof; n is from 0 to 4; and R 3 is a linear or branched, saturated or unsaturated aliphatic group having from 1 to 6 carbon atoms. Also provided are compositions comprising, and methods of use of, the compounds of the present invention.
Opening claim text (preview).
What is claimed is: 1. A compound selected from the group consisting of: and salts thereof, said salts having an anion X − preferably selected from the group consisting of acetate, benzoate, besylate, bromide, chloride, chlortheophyllinate, citrate, ethandisulfonate, fumarate, gluconate, hippurate, iodide, fluoride, lactate, laurylsulfate, malate, laeate, mesylate, methysulfate, napsylate, nitrate, octadecanoate, oxalate, pamoate, phosphate, polygalacturonate, succinate, sulfate, tartrate, and tosylate. 2. The compound of claim 1 selected from the group consisting of: and salts thereof, said salts having an anion X − preferably selected from the group consisting of acetate, benzoate, besylate, bromide, chloride, chlortheophyllinate, citrate, ethandisulfonate, fumarate, gluconate, hippurate, iodide, fluoride, lactate, laurylsulfate, malate, laeate, mesylate, methysulfate, napsylate, nitrate, octadecanoate, oxalate, pamoate, phosphate, polygalacturonate, succinate, sulfate, tartrate, and tosylate. 3. The compound of claim 1 selected from the group consisting of: and salts thereof, said salts having an anion X − preferably selected from the group consisting of acetate, benzoate, besylate, bromide, chloride, chlortheophyllinate, citrate, ethandisulfonate, fumarate, gluconate, hippurate, iodide, fluoride, lactate, laurylsulfate, malate, laeate, mesylate, methysulfate, napsylate, nitrate, octadecanoate, oxalate, pamoate, phosphate, polygalacturonate succinate, sulfate, tartrate, and tosylate. 4. The compound of claim 2 selected from the group consisting of: 5. The compound of claim 1 wherein said compound is 6. The compound of claim 1 wherein said compound is 7. The compound of claim 1 wherein said compound is 8. The compound of claim 1 wherein said compound is 9. The compound of claim 1 wherein said compound is 10. The compound of claim 1 wherein said compound is 11. The compound of claim 1 wherein said compound is 12. A composition comprising a compound of claim 1 and a vehicle wherein said composition is in a form selected form the group consisting of a mouthwash, mouth rinse, mouth spray, toothpaste, tooth gel, sub-gingival gel, mousse, foam, denture care product, dentifrice, lozenge, and chewable tablet. 13. The composition of claim 12 wherein said composition is a mouthwash comprising a carrier comprising water; and at least one surfactant selected from the group consisting of anionic, non-ionic, betaine surfactants and combinations of two or more thereof. 14. The composition of claim 13 further comprising at least one essential oil selected from the group consisting of menthol, thymol, eucalyptol, methyl salicylate, and combinations of two or more thereof. 15. The composition of claim 14 wherein said compound of claim 1 is 16. The composition of claim 14 wherein said compound of claim 1 is 17. The composition of claim 14 wherein said compound of claim 1 is 18. The composition of claim 14 wherein said compound of claim 1 is 19. The composition of claim 14 wherein said compound of claim 1 is 20. A method of inhibiting plaque in the oral cavity comprising contacting a surface of the oral cavity with a compound of claim 1 .
having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated (peptides C07K) · CPC title
Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof · CPC title
being further substituted by nitrogen atoms not being part of nitro or nitroso groups · CPC title
Guanidines · CPC title
Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.